Name | Description | Size | Catalog # | Supplier | |
---|---|---|---|---|---|
Ramucirumab ELISA Kit | human monoclonal antibody (IgG1) against vascular endothelial growth fact… | 96 tests, | abx395114 |
ABBEXA LTD |
More Info |
Cow Vascular Endothelial Growth Factor Receptor 3 / VEGFR3 (FLT4) ELISA Kit | Cow Vascular Endothelial Growth Factor Receptor 3 / VEGFR3 (FLT4)… | 96 tests, | abx572351 |
ABBEXA LTD |
More Info |
Brivanib | An ATP-competitive inhibitor of human VEGFR1 and 2 and F… | 1 mg | 23690-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
Brivanib | An ATP-competitive inhibitor of human VEGFR1 and 2 and F… | 10 mg | 23690-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
Brivanib | An ATP-competitive inhibitor of human VEGFR1 and 2 and F… | 25 mg | 23690-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
Brivanib | An ATP-competitive inhibitor of human VEGFR1 and 2 and F… | 5 mg | 23690-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
MGCD-265 | MGCD265 is a tyrosine kinase inhibitor that targets the MET, VEGFR | 5 mg | MBS8506476 |
MYBIOSOURCE INC. |
More Info |
Altiratinib | Purity ≥98% by HPLC. Altiratinib is a selective and highly potent inhib… | 5 mg, 25 mg | MBS845743 |
MYBIOSOURCE INC. |
More Info |
AMG-208 | inhibits VEGFR2 with IC50 of 112 nM. Purity > 98% (HPLC… | 50 mg, 25 mg, 10 mg, 5 mg, 2 mg | orb1227179 |
BIORBYT LTD. |
More Info |
JI-101 | type 2 (VEGFR-2), platelet derived growth fact… | 1 g, 100 mg, 250 mg | orb401826 |
BIORBYT LTD. |
More Info |
SKLB610 | SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related t… | 100 mg, 1000 mg, 250 mg, 10 mM * 1 mL in DMSO | orb181323 |
BIORBYT LTD. |
More Info |
Sorafenib (BAY-43-9006) | Sorafenib Tosylate (Bay 43-9006, Nexavar) is a multikinase inhibitor of Ra… | 1 g, 100 mg, 250 mg, 10 mM * 1 mL in DMSO | orb180764 |
BIORBYT LTD. |
More Info |
Regorafenib | (VEGFR, TIE-2), stromal (PDGFR-beta) and oncogenic (RAF… | 5 mg, 25 mg | MBS841984 |
MYBIOSOURCE INC. |
More Info |
JNJ-38158471 | JNJ-38158471(KDR) is a well tolerated, orally available, highly selective… | 1 g, 100 mg, 250 mg, 10 mM * 1 mL in DMSO | orb385522 |
BIORBYT LTD. |
More Info |
ACTB-1003 | ), angiogenesis (inhibition of VEGFR2 and Tie-2… | 5 mg, 10 mg | MBS384126 |
MYBIOSOURCE INC. |
More Info |
E-7050 (Golvatinib) | -Met (hepatocyte growth factor receptor) and VEGFR-2 (va… | 10 mg, 1 mL (in DMSO), 25 mg | MBS385394 |
MYBIOSOURCE INC. |
More Info |
CP-724714 | against EGFR, Abl, InsR, PDGFR, IRG-1R, Src, VEGFR2, c-… | 100 mg, 50 mg, 25 mg, 10 mg, 5 mg, 2 mg | orb1223133 |
BIORBYT LTD. |
More Info |
Cediranib | Cediranib (AZD2171) is a highly potent VEGFR2 inhibitor… | 1 g, 100 mg, 250 mg, 10 mM * 1 mL in DMSO | orb154671 |
BIORBYT LTD. |
More Info |
Coumarin-3-carboxylic acid | migration of lung cancer cells via EGFR/VEGFR2/c-Met-Ak… | 100 mg | orb1222092 |
BIORBYT LTD. |
More Info |
Ningetinib Tosylate | .9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively.… | 200 mg, 100 mg, 50 mg, 25 mg, 10 mg, 5 mg, 2 mg | orb1218860 |
BIORBYT LTD. |
More Info |
KRN-633 | -competitive inhibitor of VEGFR kinase activity (IC?? values of 1… | 5 mg, 25 mg | MBS842756 |
MYBIOSOURCE INC. |
More Info |
Axitinib, Free Base | Axitinib (AG-013736) is a multi-target inhibitor of VEGFR1, V… | 1 g, 500 mg, 200 mg, 10 g, 5 g, 2 g | orb60991 |
BIORBYT LTD. |
More Info |
Motesanib | (PDGFRs), and Kit receptors with IC?? values of 2 nM (VEGFR<… | 5 mg, 25 mg | MBS842289 |
MYBIOSOURCE INC. |
More Info |
Telatinib | Telatinib(Bay 57-9352) is a potent inhibitor of VEGFR2/3… | 1 g, 100 mg, 250 mg | orb363977 |
BIORBYT LTD. |
More Info |
Golvatinib (E7050) | Purity ≥98%. Golvatinib (E7050) is a dual c-Met and VEGFR-… | 1 mg, 5 mg, 10 mg | MBS579058 |
MYBIOSOURCE INC. |
More Info |
JI-101 | type 2 (VEGFR-2), platelet derived growth fact… | 50 mg, 100 mg, 25 mg, 10 mg, 5 mg, 2 mg | orb1223002 |
BIORBYT LTD. |
More Info |
Vandetanib | tyrosine kinase activity of vascular endothelial growth factor receptor <… | 200 mg, 100 mg, 50 mg, 25 mg, 10 mg | orb1225036 |
BIORBYT LTD. |
More Info |
Ningetinib | .9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively.… | 2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg | orb1220016 |
BIORBYT LTD. |
More Info |
SU 16f | , > 229-fold and > 10,000-fold selectivity over VEGFR2,… | 100 mg | orb1818531 |
BIORBYT LTD. |
More Info |
Neratinib | over a panel of 12 kinases (IC50s = >5,000 nM) but does inhibit VEGFR… | 10 mg | 18404-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
Neratinib | over a panel of 12 kinases (IC50s = >5,000 nM) but does inhibit VEGFR… | 100 mg | 18404-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
Neratinib | over a panel of 12 kinases (IC50s = >5,000 nM) but does inhibit VEGFR… | 25 mg | 18404-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
Neratinib | over a panel of 12 kinases (IC50s = >5,000 nM) but does inhibit VEGFR… | 50 mg | 18404-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
SU-5402 | ?? = 0.02 uM for VEGFR2). In addition, integrin beta4-in… | 0.5 mg, 1 mg | MBS842776 |
MYBIOSOURCE INC. |
More Info |
ENMD-2076 L- (+)-Tartaric acid | Aurora B and less potent to VEGFR2/KDR and VEGFR
5 mg, 10 mg, 1ml/10mM (in DMSO) |
MBS578700 |
|
MYBIOSOURCE INC.
More Info
|
|
RAF265 (CHIR-265) | RAF265 (CHIR-265) is a highly selective B-Raf and VEGFR2… | 1 g, 100 mg, 250 mg, 10 mM * 1 mL in DMSO | orb180818 |
BIORBYT LTD. |
More Info |
SU5402 | 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectivel… | 25 mg, 100 mg, 10 mg, 5 mg | orb1223187 |
BIORBYT LTD. |
More Info |
Sorafenib | ); inhibits VEGFR2, VEGFR3, PDGFRβ, FLT3,… | 10 mg | 10009644-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
Sorafenib | ); inhibits VEGFR2, VEGFR3, PDGFRβ, FLT3,… | 25 mg | 10009644-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
Sorafenib | ); inhibits VEGFR2, VEGFR3, PDGFRβ, FLT3,… | 5 mg | 10009644-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
Sorafenib | ); inhibits VEGFR2, VEGFR3, PDGFRβ, FLT3,… | 50 mg | 10009644-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
Sorafenib (tosylate) | ); inhibits VEGFR2, VEGFR3, PDGFRβ, FLT3,… | 10 g | 35612-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
Sorafenib (tosylate) | ); inhibits VEGFR2, VEGFR3, PDGFRβ, FLT3,… | 25 g | 35612-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
Sorafenib (tosylate) | ); inhibits VEGFR2, VEGFR3, PDGFRβ, FLT3,… | 5 g | 35612-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
Sorafenib (tosylate) | ); inhibits VEGFR2, VEGFR3, PDGFRβ, FLT3,… | 50 g | 35612-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
Chicken Vascular Endothelial Growth Factor Receptor 1 / VEGFR1 (FLT1) ELISA Kit | Chicken Vascular Endothelial Growth Factor Receptor 1 / VEGFR1 (F… | 96 tests, | abx357013 |
ABBEXA LTD |
More Info |
Human Vascular Endothelial Growth Factor Receptor 1 / VEGFR1 (FLT1) ELISA Kit | Human Receptor for Vascular Endothelial cell Growth Factor VEGF ELISA Kit… | 96 tests, | abx352262 |
ABBEXA LTD |
More Info |
Human Vascular Endothelial Growth Factor Receptor 1 / VEGFR1 (FLT1) ELISA Kit | Human Vascular Endothelial Growth Factor Receptor 1 / VEGFR1 (FLT… | 96 tests, 5 x 96 tests, 10 x 96 tests, | abx352395 |
ABBEXA LTD |
More Info |
Human Vascular Endothelial Growth Factor Receptor 3 / VEGFR3 (FLT4) ELISA Kit | Human Vascular Endothelial Growth Factor Receptor 3 / VEGFR3 (FLT… | 96 tests, | abx352039 |
ABBEXA LTD |
More Info |
Human Vascular Endothelial Growth Factor Receptor 3 / VEGFR3 (FLT4) ELISA Kit | Human Vascular Endothelial Growth Factor Receptor 3 / VEGFR3 (FLT… | 96 tests, 5 x 96 tests, 10 x 96 tests, | abx153473 |
ABBEXA LTD |
More Info |